表紙：糖尿病性潰瘍治療市場規模、シェア、成長分析、製品タイプ別、潰瘍タイプ別、エンドユーザー別、地域別- 産業予測2025～2032年

市場調査レポート

商品コード

1796440

糖尿病性潰瘍治療市場規模、シェア、成長分析、製品タイプ別、潰瘍タイプ別、エンドユーザー別、地域別- 産業予測2025～2032年

Diabetic Ulcer Treatment Market Size, Share, and Growth Analysis, By Product Type (Wound Care Dressings, Wound Care Devices), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers), By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年08月18日
発行: SkyQuest
ページ情報: 英文 198 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 786,626円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 920,204円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,053,782円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.42円

全表示
概要
目次

概要

サンプル依頼リストに入れる

糖尿病性潰瘍治療の世界市場規模は2023年に57億米ドルとなり、予測期間（2025～2032年）のCAGRは6.1%で、2024年の60億5,000万米ドルから2032年には97億1,000万米ドルに成長する展望です。

世界の糖尿病性潰瘍治療市場は、糖尿病罹患率の上昇、技術の進歩、糖尿病性潰瘍合併症に対する意識の高まりによって大きな成長を遂げています。患者数の増加により、感染を予防し治癒プロセスを合理化する効果的な治療に対するニーズが高まっています。デジタルヘルスソリューションの統合は、タイムリーな介入を可能にするだけでなく、合併症を最小限に抑えるために重要な継続的管理も容易にします。糖尿病治療に対する認識が高まったことで、より積極的なスクリーニングと個別化された治療アプローチが行われるようになり、市場の需要はさらに高まっています。AI、機械学習、IoT、ブロックチェーンなどの新たな技術は、早期発見の強化、患者エンゲージメントの向上、保険プロセスの合理化など、状況を一変させつつあります。これらのイノベーションが進化し続けることで、患者の転帰が大幅に改善され、さまざまな環境でのケア提供が最適化されます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他の欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主要市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022～2024年）
  主要企業プロファイル
  - Smith & Nephew
  - 3M Healthcare
  - ConvaTec Group Plc
  - Coloplast A/S
  - Molnlycke Health Care
  - Integra LifeSciences Corporation
  - B. Braun Melsungen AG
  - Medline Industries, Inc.
  - Organogenesis Inc.
  - Acelity L.P. Inc.
  - Derma Sciences, Inc.
  - Medtronic plc
  - Cardinal Health
  - Hollister Incorporated
  - BSN Medical GmbH
  - Hartmann Group

結論と提言

Product Code: SQMIG35D2346

Global Diabetic Ulcer Treatment Market size was valued at USD 5.7 billion in 2023 and is poised to grow from USD 6.05 billion in 2024 to USD 9.71 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The global diabetic ulcer treatment market is experiencing significant growth driven by the rising incidence of diabetes, advancements in technology, and heightened awareness of diabetic ulcer complications. An increasing patient base amplifies the need for effective treatments that prevent infections and streamline healing processes. The integration of digital health solutions not only enables timely interventions but also facilitates ongoing management, crucial for minimizing complications. Enhanced awareness around diabetic care has led to more proactive screenings and individualized treatment approaches, further fueling market demand. Emerging technologies like AI, machine learning, IoT, and blockchain are revolutionizing the landscape, enhancing early detection, improving patient engagement, and streamlining insurance processes. As these innovations continue to evolve, they significantly enhance patient outcomes and optimize care delivery across various settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetic Ulcer Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetic Ulcer Treatment Market Segments Analysis

Global Diabetic Ulcer Treatment Market is segmented by Product Type, Ulcer Type, End User and region. Based on Product Type, the market is segmented into Wound Care Dressings, Wound Care Devices and Active Therapies. Based on Ulcer Type, the market is segmented into Neuropathic Ulcers, Ischemic Ulcers and Neuro-Ischemic Ulcers. Based on End User, the market is segmented into Hospitals, Clinics, Homecare Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetic Ulcer Treatment Market

The rising prevalence of diabetes significantly increases the likelihood of developing ulcers, which in turn drives the demand for innovative treatment options. Factors such as inadequate glycemic control and insufficient awareness about preventive measures further exacerbate the recurrence of ulcers, leading to a persistent need for effective diabetic ulcer treatments. As healthcare systems globally strive to manage the complexities associated with diabetes, there is a sustained and growing demand for reliable ulcer management solutions. This ongoing challenge underscores the critical role of the global diabetic ulcer treatment market in addressing the needs of affected individuals.

Restraints in the Global Diabetic Ulcer Treatment Market

The Global Diabetic Ulcer Treatment market faces significant challenges due to the high cost associated with modern treatment options such as bioengineered skin substitutes, negative pressure wound therapy, hyperbaric oxygen therapy, and growth factor-based treatments. These advanced solutions can place a heavy financial burden on patients, as even in economically developed regions, the lack of insurance coverage for such treatments serves as a deterrent. This financial barrier can prevent individuals from seeking necessary care, ultimately limiting the market's growth potential and accessibility for those suffering from diabetic ulcers.

Market Trends of the Global Diabetic Ulcer Treatment Market

The Global Diabetic Ulcer Treatment market is witnessing a significant trend towards personalized off-loading and preventive care strategies. This shift emphasizes the importance of customized offloading techniques, which are crucial for facilitating the healing process in diabetic ulcers. Patients are increasingly embracing innovative technologies designed to adapt to their unique biomechanics and lifestyles, enhancing treatment efficacy. Concurrently, preventive solutions, including smart socks and pressure-sensing insoles, are becoming popular for their role in proactively managing foot health and preventing ulcer formation. This convergence of personalized care and technological advancement signifies a progressive approach to improving patient outcomes in the diabetic ulcer treatment landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Analysis
Customer Buying Behavior Analysis

Global Diabetic Ulcer Treatment Market Size by Product Type & CAGR (2025-2032)

Market Overview
Wound Care Dressings
Wound Care Devices
Active Therapies

Global Diabetic Ulcer Treatment Market Size by Ulcer Type & CAGR (2025-2032)

Market Overview
Neuropathic Ulcers
Ischemic Ulcers
Neuro-Ischemic Ulcers

Global Diabetic Ulcer Treatment Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Homecare Settings
Others

Global Diabetic Ulcer Treatment Market Size & CAGR (2025-2032)

North America (Product Type, Ulcer Type, End User)
- US
- Canada
Europe (Product Type, Ulcer Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Ulcer Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Ulcer Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Ulcer Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Smith & Nephew
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConvaTec Group Plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coloplast A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molnlycke Health Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organogenesis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acelity L.P. Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Derma Sciences, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hollister Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BSN Medical GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hartmann Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

糖尿病性潰瘍治療市場規模、シェア、成長分析、製品タイプ別、潰瘍タイプ別、エンドユーザー別、地域別- 産業予測2025～2032年

Diabetic Ulcer Treatment Market Size, Share, and Growth Analysis, By Product Type (Wound Care Dressings, Wound Care Devices), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers), By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と展望

主要市場の考察

糖尿病性潰瘍治療市場規模：製品タイプ別&CAGR（2025～2032年）

糖尿病性潰瘍治療市場規模：潰瘍タイプ別&CAGR（2025～2032年）

糖尿病性潰瘍治療市場規模：エンドユーザー別&CAGR（2025～2032年）

糖尿病性潰瘍治療市場規模&CAGR（2025～2032年）